TOLERABILITY OF A NEW HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% PREPARATION IN PRIMARY IMMUNODEFICIENCY DISEASES

被引：0
|
作者：
Gupta, S.
Stein, M.
Melamed, I.
Hussain, I.
Paris, K.
Engl, W.
Mccoy, B.
Rabbat, C.
Yel, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2016年 / 117卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
O015
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [21] Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study
    Sleasman, John W.
    Lumry, William R.
    Hussain, Iftikhar
    Wedner, H. James
    Harris, James B.
    Courtney, Kecia L.
    Mondou, Elsa
    Lin, Jiang
    Stein, Mark R.
    IMMUNOTHERAPY, 2019, 11 (16) : 1371 - 1386
  • [22] MECHANISM OF ACTION AND LONG-TERM TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNE GLOBULIN 10% (HYQVIA [IGHY]) IN PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)
    Melamed, Isaac
    Gupta, Sudhir
    Sehinovych, Ihor
    Hermann, Corinna
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    MUSCLE & NERVE, 2018, 58 : S50 - S50
  • [23] Real-World Evaluation of Efficacy and Tolerability of Immune Globulin Subcutaneous 16.5% in the Treatment of Patients with Primary Immunodeficiency
    Herrscher, Richard
    Langford, Jeffrey
    Kuten, Samantha
    Van Anglen, Lucinda
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB33 - AB33
  • [24] Efficacy Analysis of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)
    Schiff, R. I.
    Wasserman, R. L.
    Melamed, I.
    Stein, M.
    Engl, W.
    Leibl, H.
    Gelmont, D.
    Grossman, W. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB15 - AB15
  • [25] Efficacy, Safety, Tolerability, and Pharmacokinetics of Human Immune Globulin Subcutaneous, 20% (IGSC 20%): Final Analysis of a Phase 2/3 Study in Patients with Primary Immunodeficiency Disease (PIDD) in North America
    Suez, Daniel
    Melamed, Isaac
    Hussain, Iftikhar
    Stein, Mark R.
    Gupta, Sudhir
    Paris, Kenneth
    Fritsch, Sandor
    Bourgeois, Christelle
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB221 - AB221
  • [26] Tolerability and Efficacy of 20% Subcutaneous Immune Globulin (ScIg) Delivered by Rapid Push
    Kim, J. Y.
    Kuryan, J.
    Bonagura, V. R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB109 - AB109
  • [27] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20%: INTERIM ANALYSIS OF A PHASE 2/3 STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Krivan, Gergely
    Borte, Michael
    Marodi, Laszlo
    Derfalvi, Beata
    Dicso, Ferenc
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Schiff, Richard I.
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 728 - 728
  • [28] Safety and Tolerability of Human Immune Globulin Subcutaneous, 20% (IGSC 20%): Analysis of a Phase 2/3 Study in Patients with Primary Immunodeficiencies (PID) in Europe
    Krivan, G.
    Derfalvi, B.
    Dicso, F.
    Engl, W.
    McCoy, B.
    Leibl, H.
    Schiff, R. I.
    Yel, L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S309 - S310
  • [29] TOLERABILITY AND EFFICACY OF FACILITATED-SUBCUTANEOUS INFUSION OF IMMUNE GLOBULIN (HUMAN), 10% AND RECOMBINANT HUMAN HYALURONIDASE (IGHY) IN PATIENTS (PTS) WITH PRIMARY IMMUNODEFICIENCY DISEASE (PIDD)
    Stein, M.
    Wasserman, R. L.
    Melamed, I.
    Rubinstein, A.
    Engl, W.
    Leibl, H.
    McCoy, B.
    Gelmont, D.
    Schiff, R. I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A95 - A95
  • [30] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human) 10% AND Recombinant Human Hyaluronidase (IGHy) in a Subset of Study Patients with Primary Immunodeficiency (PI)
    Wasserman, Richard
    Melamed, Isaac
    Stein, Mark
    Puck, Jennifer
    Gupta, Sudhir
    Engl, Werner
    Leibl, Heinz
    Gelmont, David
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 367 - 367
12345